Strensiq (asfotase alfa)

pCPA File Number: 20995

Negotiation Status:

Concluded with an LOI

Indication(s):

Pediatric-onset hypophosphatasia

Sponsor/Manufacturer:

Alexion Pharma GmbH

CDA-AMC Project Number:

Not Applicable

pCPA Engagement Letter Issued:

2017-06-07

Negotiation Process Concluded:

2018-01-09